Casdin Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,000,000
| Closed | -$4.14M | – | 42 |
|
|
2022
Q2 | $4.14M | Buy |
+1,000,000
| New | +$4.14M | 0.35% | 32 |
|
|
2021
Q3 | – | Sell |
-550,000
| Closed | -$6.58M | – | 57 |
|
|
2021
Q2 | $6.58M | Hold |
550,000
| – | – | 0.17% | 47 |
|
|
2021
Q1 | $6.89M | Sell |
550,000
-530,000
| -49% | -$6.64M | 0.21% | 43 |
|
|
2020
Q4 | $16.9M | Hold |
1,080,000
| – | – | 0.5% | 38 |
|
|
2020
Q3 | $10.2M | Sell |
1,080,000
-375,000
| -26% | -$3.54M | 0.46% | 35 |
|
|
2020
Q2 | $13M | Hold |
1,455,000
| – | – | 0.77% | 30 |
|
|
2020
Q1 | $9.27M | Hold |
1,455,000
| – | – | 0.98% | 31 |
|
|
2019
Q4 | $12.2M | Hold |
1,455,000
| – | – | 1.12% | 26 |
|
|
2019
Q3 | $13.2M | Sell |
1,455,000
-75,000
| -5% | -$679K | 1.36% | 23 |
|
|
2019
Q2 | $16.5M | Buy |
1,530,000
+450,000
| +42% | +$4.85M | 1.54% | 21 |
|
|
2019
Q1 | $10.3M | Hold |
1,080,000
| – | – | 1.13% | 22 |
|
|
2018
Q4 | $12.4M | Sell |
1,080,000
-920,000
| -46% | -$10.6M | 2.12% | 19 |
|
|
2018
Q3 | $33.9M | Buy |
2,000,000
+600,000
| +43% | +$10.2M | 4.12% | 12 |
|
|
2018
Q2 | $19.9M | Hold |
1,400,000
| – | – | 2.78% | 17 |
|
|
2018
Q1 | $26.6M | Hold |
1,400,000
| – | – | 4.68% | 10 |
|
|
2017
Q4 | $23M | Hold |
1,400,000
| – | – | 5.59% | 8 |
|
|
2017
Q3 | $21M | Hold |
1,400,000
| – | – | 5.93% | 4 |
|
|
2017
Q2 | $12.3M | Buy |
1,400,000
+550,000
| +65% | +$4.84M | 4.56% | 7 |
|
|
2017
Q1 | $4.42M | Buy |
+850,000
| New | +$4.42M | 2.61% | 12 |
|